Form 4 for TECH Bio-Techne
Accepted 2024-10-28 00:00:00 ET · period of report 2024-10-24 · accession 0001062993-24-018031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-28 | 2024-10-24 | TECH | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +1,462 | 48.2K | +3% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +3,511 | 3,511 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-24 | A | A | 1,462 | $0.00 | 48,196 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-10-24 | A | A | 3,511 | $0.00 | 3,511 | D | $68.37 · — to 2034-10-24 | 3,511 Common Stock | (F1) The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders. |